Keywords: deep sequencing, non-small cell lung cancer, TCR/BCR repertoire, tertiary lymphoid structure Abbreviations: ADC, adenocarcinoma; BCR, B cell receptor; CDR3, complementarity-determining region 3; DC, dendritic cell; Foll-B cell, follicular B cell; IgH, immunoglobulin heavy chain; LCC, large-cell carcinoma; NGS, next-generation sequencing; NSCLC, non-small cell lung cancer; NT, non-tumoral distant tissue; P, peripheral blood or draining lymph node; SCC, squamous cell carcinoma; TFH, follicular helper T cell; TRM, tissue resident-memory T cell; TCR, T cell receptor; TLS, tertiary lymphoid structure.T and B cell receptor (TCR and BCR, respectively) Vb or immunoglobulin heavy chain complementarity-determining region 3 sequencing allows monitoring of repertoire changes through recognition, clonal expansion, affinity maturation, and T or B cell activation in response to antigen. TCR and BCR repertoire analysis can advance understanding of antitumor immune responses in the tumor microenvironment. TCR and BCR repertoires of sorted CD4 C , CD8C or CD19 C cells in tumor, non-tumoral distant tissue (NT), and peripheral compartments (blood/draining lymph node [P]) from 47 non-small cell lung cancer (NSCLC) patients (age median D 68 y) were sequenced. The clonotype spectra were assessed among different tissues and correlated with clinical and immunological parameters. In all tissues, CD4C and CD8 C TCR repertoires had greater clonality relative to CD19 C BCR. CD4 C T cells exhibited greater clonality in NT compared to tumor (p D 0.002) and P (p < 0.001), concentrated among older patients (age > 68). Younger patients exhibited greater CD4 C T cell diversity in P compared to older patients (p D 0.05), and greater CD4 C T cell clonality in tumor relative to P (p < 0.001), with fewer shared clonotypes between tumor and P than older patients (p D 0.04). More interestingly, greater CD4C and CD8 C T cell clonality in tumor and P, respectively (both p D 0.05), correlated with high density of tumor-associated tertiary lymphoid structure (TLS) B cells, a biomarker of higher overall survival in NSCLC. Results indicate distinct adaptive immune responses in NSCLC, where peripheral T cell diversity is modulated by age, and tumor T cell clonal expansion is favored by the presence of TLSs in the tumor microenvironment.